BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24215673)

  • 1. Rohitukine, a chromone alkaloid and a precursor of flavopiridol, is produced by endophytic fungi isolated from Dysoxylum binectariferum Hook.f and Amoora rohituka (Roxb).Wight & Arn.
    Kumara PM; Soujanya KN; Ravikanth G; Vasudeva R; Ganeshaiah KN; Shaanker RU
    Phytomedicine; 2014 Mar; 21(4):541-6. PubMed ID: 24215673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusarium proliferatum, an endophytic fungus from Dysoxylum binectariferum Hook.f, produces rohitukine, a chromane alkaloid possessing anti-cancer activity.
    Mohana Kumara P; Zuehlke S; Priti V; Ramesha BT; Shweta S; Ravikanth G; Vasudeva R; Santhoshkumar TR; Spiteller M; Uma Shaanker R
    Antonie Van Leeuwenhoek; 2012 Feb; 101(2):323-9. PubMed ID: 21898150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of rohitukine in leaves and seeds of Dysoxylum binectariferum: an alternate renewable resource.
    Mahajan V; Sharma N; Kumar S; Bhardwaj V; Ali A; Khajuria RK; Bedi YS; Vishwakarma RA; Gandhi SG
    Pharm Biol; 2015 Mar; 53(3):446-50. PubMed ID: 25472605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysoxylum binectariferum Hook.f (Meliaceae), a rich source of rohitukine.
    Mohanakumara P; Sreejayan N; Priti V; Ramesha BT; Ravikanth G; Ganeshaiah KN; Vasudeva R; Mohan J; Santhoshkumar TR; Mishra PD; Ram V; Shaanker RU
    Fitoterapia; 2010 Mar; 81(2):145-8. PubMed ID: 19686817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambient ionization mass spectrometry imaging of rohitukine, a chromone anti-cancer alkaloid, during seed development in Dysoxylum binectariferum Hook.f (Meliaceae).
    Mohana Kumara P; Srimany A; Ravikanth G; Uma Shaanker R; Pradeep T
    Phytochemistry; 2015 Aug; 116():104-110. PubMed ID: 25799183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rohitukine content across the geographical distribution of
    Varun E; Bhakti K; Aishwarya K; Suraj RH; Jagadish MR; Mohana Kumara P
    Heliyon; 2023 Feb; 9(2):e13469. PubMed ID: 36852056
    [No Abstract]   [Full Text] [Related]  

  • 7. A chromatography-free isolation of rohitukine from leaves of Dysoxylum binectariferum: Evaluation for in vitro cytotoxicity, Cdk inhibition and physicochemical properties.
    Kumar V; Guru SK; Jain SK; Joshi P; Gandhi SG; Bharate SB; Bhushan S; Bharate SS; Vishwakarma RA
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3457-63. PubMed ID: 27363938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of rohitukine-enriched fraction of Dysoxylum binectariferum Hook.f. (leaves) as anti-arthritic phytopharmaceutical candidate: Chemical standardization, in-vivo validation, formulation development and oral pharmacokinetics.
    Kumar V; Bharate SS; Bhurta D; Gupta M; Gandhi SG; Singh D; Jaglan S; Kumar A; Vishwakarma RA; Bharate SB
    J Ethnopharmacol; 2020 May; 254():112758. PubMed ID: 32165175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new alkaloid from Dysoxylum binectariferum.
    Yang DH; Cai SQ; Zhao YY; Liang H
    J Asian Nat Prod Res; 2004 Sep; 6(3):233-6. PubMed ID: 15224423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraceptive and hormonal properties of the stem bark of Dysoxylum binectariferum in rat and docking analysis of rohitukine, the alkaloid isolated from active chloroform soluble fraction.
    Keshri G; Oberoi RM; Lakshmi V; Pandey K; Singh MM
    Contraception; 2007 Nov; 76(5):400-7. PubMed ID: 17963866
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Kumara PM; Varun E; Sanjay JR; Madhushree AH; Thimmappa R
    Front Plant Sci; 2023; 14():1098987. PubMed ID: 37636089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desorption Electrospray Ionization (DESI) Mass Spectrometric Imaging of the Distribution of Rohitukine in the Seedling of Dysoxylum binectariferum Hook. F.
    Mohana Kumara P; Srimany A; Arunan S; Ravikanth G; Uma Shaanker R; Pradeep T
    PLoS One; 2016; 11(6):e0158099. PubMed ID: 27362422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenously Applied Rohitukine Inhibits Photosynthetic Processes, Growth and Induces Antioxidant Defense System in
    Ahmed S; Asgher M; Kumar A; Gandhi SG
    Antioxidants (Basel); 2022 Aug; 11(8):. PubMed ID: 36009231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evaluation of the efficacy of Dysoxylum binectariferum stem bark and its active constituent rohitukine in regulation of dyslipidemia in rats.
    Mishra SK; Tiwari S; Shrivastava S; Sonkar R; Mishra V; Nigam SK; Saxena AK; Bhatia G; Mir SS
    J Nat Med; 2018 Sep; 72(4):837-845. PubMed ID: 24677095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysoxylum binectariferum bark as a new source of anticancer drug camptothecin: bioactivity-guided isolation and LCMS-based quantification.
    Jain SK; Meena S; Gupta AP; Kushwaha M; Uma Shaanker R; Jaglan S; Bharate SB; Vishwakarma RA
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3146-9. PubMed ID: 24878199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Chromone Alkaloid, Rohitukine, Affords Anti-Cancer Activity via Modulating Apoptosis Pathways in A549 Cell Line and Yeast Mitogen Activated Protein Kinase (MAPK) Pathway.
    Safia ; Kamil M; Jadiya P; Sheikh S; Haque E; Nazir A; Lakshmi V; Mir SS
    PLoS One; 2015; 10(9):e0137991. PubMed ID: 26405812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin-dependent kinase inhibition by flavoalkaloids.
    Jain SK; Bharate SB; Vishwakarma RA
    Mini Rev Med Chem; 2012 Jun; 12(7):632-49. PubMed ID: 22512551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroprotective effect of anti-cancer compound rohitukine: possible role of gastrin antagonism and H(+) K (+)-ATPase inhibition.
    Singh N; Singh P; Shrivastva S; Mishra SK; Lakshmi V; Sharma R; Palit G
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Mar; 385(3):277-86. PubMed ID: 22113419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome analysis and differential expression in Arabidopsis thaliana in response to rohitukine (a chromone alkaloid) treatment.
    Ahmed S; Chouhan R; Junaid A; Jamwal VL; Thakur J; Mir BA; Gandhi SG
    Funct Integr Genomics; 2023 Jan; 23(1):35. PubMed ID: 36629976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, Tissue Distribution and Plasma Protein Binding Studies of Rohitukine: A Potent Anti-hyperlipidemic Agent.
    Chhonker YS; Chandasana H; Kumar A; Kumar D; Laxman TS; Mishra SK; Balaramnavar VM; Srivastava S; Saxena AK; Bhatta RS
    Drug Res (Stuttg); 2015 Jul; 65(7):380-7. PubMed ID: 25243649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.